Nathan Connell on the 1st von Willebrand Factor/Factor VIII Relevance Academy
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:
”We recently held the first von Willebrand Factor/Factor VIII Relevance Academy in Orlando, Florida.
It was a wonderful day of learning and discussion about so many topics of importance to the hemostasis community.
From basic science to clinical and epidemiologic applications, I was excited to see so much focus on improving the quality of life for those with inherited bleeding disorders.
I was asked to present on the role of VWF concentrate prophylaxis in people with von Willebrand disease.
We have more data now than we did when the international VWD guidelines were published in 2021.
Still, we continue to have so many questions about who would benefit the most and how to optimize our prophylaxis strategies.
Thank you to the always outstanding Octapharma team, including Stefano Carta, Belyanskaya Larisa, Claudio Sandoval, and many others, as well as Academy chair Robert Sidonio, and all the faculty and participants who contributed to the discussion.”
Stay updated with Hemostasis Today.
-
Dec 9, 2025, 04:47Grigoris Gerotziafas: 3 ASH 2025 Poster Awards for Our Team!
-
Dec 9, 2025, 04:22Ibtesam Alsufyani on RBC Exchange: A Life-Saving Apheresis Procedure
-
Dec 9, 2025, 04:02Susan Shea on Advancement of Precision Platelet Transfusion Medicine
-
Dec 9, 2025, 03:50Ravi C Dara Shares WHO’s Phase A guidance for PBM from ISBT
-
Dec 9, 2025, 03:39Low Platelets in Pregnancy: A Clinical Reality Check from Abdul Mannan
-
Dec 9, 2025, 03:26Michael Dunn Reflects on all ASH25 Represents for the Bleeding Disorders Community
-
Dec 9, 2025, 03:24Arun V J: Blood Loss Isn’t Always an Emergency and Blood Isn’t Always the Answer
-
Dec 8, 2025, 22:24ASH25 Day 3: Don’t Miss The Highlights
-
Dec 8, 2025, 15:09Paul Bolaji Invites You to Nigerian Stroke Leaders’ Summit 2025